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Abstract 
Following the previous study done in 2005, the radiological application in medicine was updated, 
extending to 2011. The economic scale of the application of radiation in medicine and dentistry in 
2011 was 21,495M$, which increased 1.6 times over 2005. This expansion is attributed to the 
innovative development in technology at the diagnostic imaging and the radiotherapy (RT). The 
economic scales of these medical practices were 16,907M$ and 1,774M$, respectively increasing 1.4 
and 1.8 times over 2005.  
Keywords: Application of radiation; medicine; agricaulture; economic scale 
1.  Introduction 
   Electricity generated by the Japanese nuclear power plants (NPP) was relatively cheap and has been contributed 
markedly to a build up of social infrastructure of Japan since 1966. Its economic scale was as much as 50 million 
dollars (hereinafter abbreviated as M$) at the beginning. After 30 years, the scale increased up to 58,659M$ (1995). 
The first disaster was happened as the Niigata Chuetsu Offing in 2007. Subsequently, the Great East Japan 
Earthquake on March 11, 2011 was happened. The economic scale after these made the situation worse, declining to 
3,383M$ in 2012; one-twentieth of the peak.  
   Apart from the innovation in the generation of new energy, there exists the other important innovation in the 
radiological application. Principally, it is not aimed at producing a cheap and clean energy, but aimed at increasing 
welfare of the Japanese people’s ordinary life. According to our previous study [1, 2] the radiological application in 
medicine was recognized as the key field in the radiological application. The economic scale was 10,305 M$ in 
1997 and 13,641M$ in 2005. In 2005, the economic scale corresponded to approximately 4.5% of the national 
medical expenditures (300b$) or about 0.3% of the Gross Domestic Products (GDP; 4,572b$) in Japan.  
   In the present paper, the data covering from 2005 to 2011; six years period after the last study㩷 were renewed. This 
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time a technological innovation developed in the medical field is focused. Additionally, a biological innovation 
observed in the agriculture is also described.    
2. Methodology 
2.1 Reimbursement 
   The concept for the economic scale of radiology in medicine was discussed in detail and reported elsewhere [3]. 
With respect to a cancer treatment, for example, the primary disciplines are medical (internal medicine) oncology 
with drugs, surgical oncology with surgery and radiation oncology with radiation. Of course, the final goal of them 
is to extend the time span of the life for human beings. From the viewpoint of economic scale, it is very hard to 
measure the time span by means of money.    
 Alternatively, the reimbursements-the receipts issued as the results of medical care was used. Fortunately, the 
Ministry of Labor, Health and Welfare (hereinafter abbreviated as MLHW) [4] reports this kind of data every year 
in the form of the Socio/Medical Diagnostic Acts (hereinafter denoted as the book). In the book, the radiation 
oncology was divided into two main fields; medicine and dentistry. Each field consisted of the three large items, that 
is, the examination with radioisotopes (RI), the diagnostic imaging, and the radiotherapy (RT). Note that a magnetic 
resonance imaging (MRI) is a part of diagnosis imaging, however, the author considered it non-radiological 
application and omitted hereinafter. Normally, a total of 45 small items for medicine and 13 small items for dentistry 
were included in the book in the form of medical care points and operation times a month. 
   In the past, there occurred two significant systematic changes in the book, which affects the objectives of the 
present study. The first occurred in the year 1999; the MLHW combined an associated health insurance with the 
national and the governmental ones. This enlarged the magnitude of database. The second occurred in the year 2003; 
the MLHW decided to apply the diagnosis procedure combination (DPC) rule to the examination with RI and the 
diagnostic imaging. DPC in dentistry started later on (2003) but not discussed here due to a very small magnitude.   
   With respect to the first incident, the adjusting factor “f”, the ratio between the national medical expenditures and 
the total reimbursements measured from the book was set up. With respect to the second incident, it was assumed 
that 4% of total DPC reported in the book belonged to the radiological application. Consequently, the medical care 
point for radiological application reported in the book can be converted into the reimbursements (money) as follows; 
{Medical care point/month}×12 months×10 yen / point×{1.46̚1.77}+0.04DPC࡮࡮(1) 
Where, {1.46̚1.77} is the adjusting factor “f” changed from year to year. It is worthy of mentioning that the 
economic scale expressed by the equation (1) is only for three large items; the examination with RI, diagnostic 
imaging and the RT. The economic scale of many small items included in them is only expressed by using the first 
and second terms in the equation hereinafter. Usually, the publication of the book is delayed two years due to the 
statistics. Hence, as of 2013, the book available was data from 2011.    
2.2. Conversion from Japanese yen to US dollar 
   A conversion rate from Japanese yen (\) to the U. S. dollar ($) was, for example, 1$=120.92\ for 1997, 
1$=110.21\ for 2005, and 1$=79.78\ for 2011. The year average rate was obtained from the Bank of Japan [5]. The 
rate conversion in some times accompanies necessary evil. It was seen that the original Japanese data was somewhat 
distorted although not significantly, through the rate conversion process.         
3. Results and discussion 
3.1. Radiological reimbursements and the national medical expenditures 
   Figure 1 shows the economic scale of the radiological reimbursement determined by equation (1), where the 
national medical expenditures (circles) are plotted together. It is revealed that the radiological reimbursements are 
almost proportional to that of the national medical expenditures. The occupational ratio is almost 4.3%, that is, 3.9% 
for medicine and 0.3% for dentistry in the average of past 20 years. This behavior might be the result of a strong in-
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house regulation in the related society. In 1992, the reimbursement in medicine was 7,824M$ and the national 
medical expenditure was 185,424M$. In 2005, the former increased to 13,641M$ and the latter enlarged to 
300,598M$. Now in 2011, the former was 21,495M$ and the latter was 483,472M$. In 2011, the medical 
reimbursement is advanced by a factor of 1.6 (21,495/13,641) than that of 2005. During the past 20 years, the 
medical reimbursement increased about 3 times (21,495/7,824). It corresponded to 0.4% of the nominal GDP in 
Japan. The increase means the heavy taxation of the people. Note that an average life of Japanese in 1990 was 75.9 
for men and 81.9 for women. In 2009, it was 79.6 for men and 86.4 for women. In the course of 19 years, the life 
extension for Japanese was 4 years for men and 5 years for women; Japanese is proud of being top-ranked in 
longevity. To reveal a relationship between the significant increase of the radiological economic scale and the life 
extension of Japanese is very much important but there is no measure to do so.         
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Fig.1 Economic scale of the national medical expenditures (circle, left-hand side) and the reimbursements in the 
medicine (column, right-hand side). 
3.2. Inspection, Diagnostic Imaging and Radiotherapy (RT) 
   In the previous study [2], it was revealed that X-ray equipment for diagnosis, radiation related medical equipments 
and products, particle accelerator for treatment and so on had a big market having the economic scale of 
3,052M$ for 1997 and 3,863M$ for 2005. In RT, a variety of radiation technology has developed. In the followings, 
the economic scale of the inspection with the RI, the diagnostic imaging and the RT in medicine in 2011 were 
discussed. It is worthy of mentioning that medical facilities in 2005 were 173,200 in our country. 
(1)Inspection 
As shown in Fig.2, the economic scale of inspection with the RI is not significant. In 1992, it had the economic 
scale of 3.1M$ with the 3,920 operations, but now (2011) it had the economic scale of 0.3M$ with the 418 
operations. The economic scale in 2011 is one-tenth the earlier period. For past 20 years, the economic scale did not 
exceed 4M$ and the operation times were less than 5,000 a year. Note that there is no RI utilization in dentistry. 
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Fig.2  Economic scale of the inspection with the RI, the diagnostic imaging and the RT in medicine.
(2)Diagnostic Imaging 
   The diagnostic imaging had the largest economic scale throughout the period (Fig.2). For 20 years ago (1992), it 
had the economic scale of 6,660M$ with the 31,252,926 operations, but now (2011) it had the economic scale of 
16,907M$ with the 22,150,775 operations. The economic scale in 2011 is 2.5 times (16,907/6,660) the earlier 
period; the economic scale tends to increase further. In Table 1, three major small items included in the diagnostic 
imaging are shown. The magnitude of the economic scale is of the order of CT, X-ray simple and nuclear medicine. 

  Table 1 Major three small items included in the diagnostic imaging 
Year 2011 M$ %
㽲Simple X-ray 5,458 37
㽳Nuclear Medicine 1,442 10
㽴CT 7,954 54
Sum 14,854 100
Note: MRI in this year is 2,579M$
   In the followings, three typical and practical usages of diagnostic imaging together with innovative matters were 
introduced. 
   The first is the nuclear medicine. As shown in Fig.3, this was already activated from 20 years ago having an 
economic scale as much as 617M$, where the operations were as many as 120,470. The economic scale was 
increased year by year and presently it becomes 1,442M$ with the operation times by 169,000. Comparing with 20 
years ago, the economic scale is about twice. The typical innovative tool worked as the developer was FDG-PET, 
the economic scale of which in 1997 [3] was 50M$ for the U. S., and 2M$ for Japan. Unit cost was about 1,980$ for 
the former and about 397$ for the latter. In 2005, Japan Radioisotope Association (JRIA) studied an economic scale 
of FDG-PET by questionnaire survey over the existing 99 facilities. From replied 68, one found that examinations in 
total were 50,558. A cost of reimbursement in public and private hospitals varied from zero (13%), 816$ (18%) and 
1,020$ (69%). By using weighed average of 981$, a rebated cost for 99 facilities is 72M$ (50,558 x 981$ x (99/68)). 
It is 36 times the 1997.
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Fig.3 Economic scale of nuclear medicine as one of diagnostic imaging 
    The second is the breast cancer known as a typical disease of females. Naturally, the cancer occurs also in males, 
though it is less common. Screening of breast cancer is done by self and clinical breast palpation, X-ray 
mammography (or mammogram), MRI, ultrasonic, Miraluma (breast-specific gamma imaging) and genetic testing. 
Mammography and Miraluma are related to the radiological application. Here the latter is omitted. As shown in
Fig.4, the mammography brought innovation to Japanese females since 2006. Note that since 1987 numbers of 
examinees and consultation rates were reported annually by every local community health centers in Japan under the 
control of MHLW. As of year 2006, all data were consolidated and reimbursed medical points were begun to be 
reported.  
In 2006, the economic scale was 93M$ and the number of operations was 199,589. With respect to this topic, there 
existed additional information issued by the MHLW, where 3,366,460 females more than 40 years old (15% of the 
total) were screened by mammography combined with breast self examination in 2005; one year before 
consolidation. The cancer discovery rate was 0.27%, instead of 0.14% for without mammography. A cost necessary 
for screening varied from a place to a place due to different cost coverage by a local authority. By using an average 
value of 44$ per female, an economic scale of breast cancer relating to mammography was estimated to be 177M$. 
This statement however is not in fully agreement with the data plotting in Fig.4, perhaps due to the quality of 
screening test.  
   The third is CT (computerized tomography) imaging for a lung cancer. As of 2005 it was not reimbursed and was 
done as option at ningen (human) dock. This is a different point from the mammography because the former is 
promoting now as one of national project but the later is originally developed as a home made technology in Japan 
and its effectiveness is under discussion. This fact masks an accurate scale of economy. The Japanese Society of CT 
Screening (JSCTS) reported in 2005 [6] that the number of people screened was approximately 85,888 at 50 medical 
facilities, where an average expenditure was about 101$/person. It leads that an economic scale of lung cancer by 
CT screening was about 9M$. As shown in Fig. 5, peoples aged from 50 to 59 were the majority having a 
percentage by 35% (30,031 to 85,888 totals), where numbers of males are greater than those of females, partly 
because the screening was done mainly at a workplace.  
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Note:
According to
http://www.mhlw.go.jp/toukei/list
a breast cancer examination was carried out
since 1987, where year averaged examinees
were ranged from 1,434,000 to 3,000,000
with the consultation rate from 5.4% to
12.9%. As of 2006, an age of the female,
examination method and reimbursed points
were consolidated, therefore, an economic
scale was stared to calculate.
Fig.4 Economic scale of the mammography for breast cancer. 
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Fig.5 Economic scale of the CT imaging for lung cancer 
(3) RT 
   RT is known as the most useful treatments for various types of cancers. In the mid of 1990’s American patients 
rather than Japanese used RT aggressively to cure their disease. Once Americans had any cancers (1.15million 
patients in 1994), 49% (560,262 patients) of those received RT [7]. For Japanese, of the 440,001 new patients in 
1995, only 15% (71,696 patients) received RT. Perhaps most Japanese patients prefer to surgical operation to RT [8]. 
Many explanations exist behind this difference. With respect to cancer treatments, different attitudes exist between 
Americans and Japanese. 
   As shown in Fig.2, the RT is the second order in the economic magnitude. In 1992, it had the economic scale of 
147M$ with the 126,789 operations, but now (2011) it had the economic scale of 1,774M$ with the 382,424 
operations. The economic scale in 2011 is 12 times greater the earlier (1,774/147). RT has been developed taking 
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many innovative technologies in the process of manufacturing. RT here contains the external beam RT, the 
stereotactic RT by gamma knife, the stereotactic RT by linear accelerator, the whole body exposure, the 
electromagnetic wave thermotherapy (this is omitted hereinafter), the brachytherapy (external, intracavitary, implant, 
charged (Ir) particle), and the blood irradiation.  
a. External beam RT 
   This item (1,140M$ in 2011) consists of four sub-small items, that is, the X-rays superficial treatment, the Co-60 
remote mass irradiation, the high energy RT and the intensity-modulated radiation therapy (IMRT). As shown in 
Fig.6, the X-rays superficial treatment and the Co-60 remote mass irradiation had less economic scales. On the other 
hand, the high energy RT and IMRT tended to increase their economic scale. In 2011, the economic scale for the 
high energy RT is 1,004M$ with the operation times by 312,551 and that for the IMRT is 136M$ with the operation 
times by 18,110. The occupational ratio for the former to the external beam RT is 88% (1,004/1,140) and that for the 
latter is 12%.  
   As a typical example for the high energy RT, the charged particle therapy is described. A total number of proton 
treatments in 1997 were 59 and that of carbon treatment was 159. A total numbers 218 had no economic scale due to 
poor reimbursement at that time. In 2005, as shown in Fig.7, charged particle therapy was carried out in the 4 cancer 
centers in Japan represented by the National Cancer Center Hospital East, where numbers of treatments were totaled 
in 927 with economic scale by 24M$. 
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Fig.6 Economic scale for external beam RT; X-ray superficial treatment, Co-60 remote mass irradiation, intensity-
modulated RT (IMRT) and high energy RT 
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Fig.7. Charged particle therapy. Data was obtained from 5 hospitals, in which TSUKUBA University performed a 
clinical examination alone and does not contribute to an economic scale. 
b. Stereotactic RT by gamma knife, stereotactic RT by linear accelerator, whole body exposure, brachytherapy and 
blood irradiation. 
   The economic scales of five small items belonged to RT were increasing. In 2011, the economic scale of the whole 
body exposure is 4M$ (0.3%) with the 59 operations, the blood irradiation is 10M$ (0.6%) with the 26,684 
operations, the stereotactic RT by gamma knife is 114M$ (8%) with the 913 operations, the stereotactic RT by linear 
accelerator is 149M$ (10%) with the 942 operations, and the brachytherapy is 95M$ (6%) with the 2,175 operations, 
respectively. A total of those are 372M$ (25%). The results of discussion in this section are summarized in Table 2.
     Table 2 Medical items included in RT in 2011 
Medical items in RT in 2011 M$ %
External beam RT 1,140 75
Stereotactic RT by gamma knife 114 8
Stereotactic RT by linear accelerator 149 10
Whole body exposure 4 0.3
Brachytherapy 95 6
Blood Irradiation 10 1
Sum 1,512 100
   As a whole, the RT in medicine is 1,512M$ for 2011; the value is approximately the twice of the earlier period 
(2005). The biggest economic scale is the external beam RT by 1,140M$ (75%), in which the high energy RT is one 
part having the economic scale by 1,004M$. Note that the economic scale of RT in dentistry is recently revealed. In 
2011, it was 7M$, where the high energy RT occupied the highest as much as 5.6M$. A recent innovation in RT 
seems to be addressed to the high energy RT.               
   Next, the brachytherapy for prostate cancer, which is known to be a typical disease of male is described. This was 
the most common malignant neoplasm among Americans in 1997. The rate of prostate cancer in the U. S. is 7 times 
larger than in Japan, implying that Americans have a constitutional predisposition to prostate cancer. Application of 
RT is 30% for Americans and only 5% for the Japanese. For the latter, hormone therapy is applied frequently. Cost 
per radiotherapy course is, to our surprise, cheaper in Japan (3,306$) than that in the U. S. (15,000$), by a factor of 
1/5. Economic scale of the prostate cancer is 576 M$ for the U. S., and 0.72 M$ for Japan in 1997. No measurement 
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was done for 2005.  
   In Table 3, a summary of the present study is shown.   
    Table 3 Summary of the radiological application in the selected years 
Unit: M$ 1997 2005 2011
Medicine+dentistry 10,305 13,641 21,495
㽲Inspection with RI 2 0.4 0.3
㽳Diagnostic Imaging 8,568 12,242 16,907
㽴RT 466 977 1,774
Note: (1) The economic scale of the first row is determined according to equation (1), namely DPC and the fitting factor are 
taken into consideration. (2) The economic scale from second to fourth rows is for medicine, where DPC and the fitting factor 
were not considered due to technical term to term comparison. 
Note that Table 3 is resulted from a comparison of large terms, therefore, the RT in 2011 (1,774M$) is bigger than 
that of Table 2 (1,512M$). Table 2 is resulted by the small term to term comparison, not including managing 
charges and medical care compensations. The economic scale of medicine and dentistry for 2011 was 2 times the 
1997 and 1.6 times the 2005. This finding implies that the radiological application in the medicine is still expanding, 
together with the extension of average life in Japanese. Fig.8 shows the economic scale of radiological application 
in medicine in 2011. It is revealed that the magnitude is of the order of the diagnostic imaging (91%) and the RT 
(9%), where the inspection with RI is negligible. The economic scale of the RT for 2011 is the two times the 2005 
(1774/977). 
㽲Inspection
with RI ,
0.3M$, 0.3%
㽴RT ,
1,774M$, 9%
㽳Diagnostic
Imaging,
16,907M$,
91%
Fig.8 Economic scale of medicine in 2011; a total of 18,681M$ taking into no consideration of DPC and fitting 
factor
3.3. RI usage in agriculture 
   For laboratory work for RI provision, biological studies, and RI waste disposal, the total economic scale was about 
2M$ for 2005 and 4M$ 1997. Isotopes of 3H, 14C, 32P, 35S and 125I are important for agricultural and biological 
studies, while 137Cs is useful for studying fall out. Economic scales of the first three in 1997 were 0.5M$ 0, 6M$ and 
0.2M$, respectively. The latter two contribute a further 0.3M$ each. The use of 32P as a tracer is the largest and has 
increased in the area of gene engineering having a total retail cost of 1.6M$ per year.
   Economic scale of RI utilization in agriculture is 4M$ for R&D, 127M$ for environmental protection and 
1M$ for chronology. A total sum is 132 M$ for 2005 and 24M$ for 1997. According to the Cabinet [2], the 
economic scale of agriculture is 2,527M$ for 2005 and 2,572M$ for 1997. The share of RI usage in agriculture is 
about 5% for 2005 and 1% for 1997. Even though, the amount is quite small in magnitude. RI usage in agriculture 
was increased by a factor of 5.      
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4. Conclusions 
 Application of radiological technology in the field of medicine and dentistry in Japan was studied up to 2011 by 
the economic scale as the measure.  
z The economic scale of medicine and dentistry was 10,305M$ in 1997, 13,641M$ in 2005 and 
21,495M$ in 2011, respectively. The radiological activities in medicine are still expanding. The 
magnitude of the economic scale was expanded by a factor of 1.6 (21,495/13,641) from the previous 
study done in 2005. An occupational ratio of radiological application to the GDP was of the order of 0.4%.    
z In medicine, the radiological application was used in the inspection with RI, the diagnostic imaging, and 
the RT. The economic scale for 2011 was respectively 0.3M$, 16,907M$ and 1,774M$, where the RT in 
dentistry is 7M$. In medicine during the past 6 years, the diagnostic imaging and the RT are expanded by 
a factor of 1.4 and 1.8. The main developers in the former are the X-ray, the nuclear medicine and the CT. 
On the other hand, the prominent developer in the latter is the external beam RT, represented by the high 
energy RT.      
z For laboratory work for RI provision, biological studies, and RI waste disposal, the total economic scale 
was about 2M$ for 2005. Isotopes of 3H, 14C, 32P, 35S and 125I are important for agricultural and biological 
studies.
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